Latest news

Filters (1)
January 18, 2021

Phase II Research Against Covid-19 Launched in France with Debiopharm’s Antiviral Alisporivir

Read more
September 8, 2015

Debiopharm International SA and Solid Biosciences, LLC, announce a collaboration to explore the use of Alisporivir (Debio 025) in muscular…

Read more
January 12, 2015

Debiopharm Group regains full rights to Alisporivir program

Read more
February 9, 2010

Debiopharm Group™ grants an exclusive licence for the development, manufacture and commercialisation of Debio 025 – A potent, first-in-class antiviral…

Read more
April 30, 2009

Clinical Update – Debio 025 in Hepatitis C – Debiopharm starts phase IIb study after record time patient randomisation

Read more
April 28, 2009

Clinical Update – Debio 025 in Hepatitis C – Debiopharm presents promising phase IIa results showing potent antiviral activity

Read more
January 26, 2009

Clinical Update – Debio 025 in Hepatitis C – Debiopharm starts phase IIb triple therapy study, a promising therapeutic avenue

Read more
April 28, 2008

Clinical Update – Debio 025 in Hepatitis C – Presentation of Phase IIa Efficacy Results

Read more
April 19, 2007

Clinical update – Debio 025 cyclophilin inhibitor for the treatment of HCV – A unique viral kinetics

Read more